Income Taxes (Details Narrative) (USD $)	3 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 6,179,578
Net operating loss carry forwards	18,175,231
Amount of NOL acuired in reverse aquisition fo BMSG	38,616
Amount of NOL attributable to Bio-Matrix Scientific Group, Inc.	$ 18,136,615
Federal Corporate income tax Rate	34.00%